Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.
about
In vivo protein stabilization based on fragment complementation and a split GFP system.Chemical glycosylation of cytochrome c improves physical and chemical protein stability.Arginine and the Hofmeister Series: the role of ion-ion interactions in protein aggregation suppression.Analytical detection and characterization of biopharmaceutical glycosylation by MS.Non-viral nanovectors for gene delivery: factors that govern successful therapeutics.The importance of interfaces in protein drug delivery - why is protein adsorption of interest in pharmaceutical formulations?Biopharmaceutical formulations for pre-filled delivery devices.Improving patient tolerability in immunoglobulin treatment: focus on stabilizer effects.Post-production protein stability: trouble beyond the cell factory.Production methods and stabilization strategies for polymer-based nanoparticles and microparticles for parenteral delivery of peptides and proteins.Comparative Effects of Metal-Catalyzed Oxidizing Systems on Carbonylation and Integrity of Therapeutic Proteins.Development of separation technology for the removal of radium-223 from targeted thorium conjugate formulations. Part II: purification of targeted thorium conjugates on cation exchange columns.Organophosphate-Hydrolyzing Enzymes as First-Line of Defence Against Nerve Agent-Poisoning: Perspectives and the Road Ahead.Design and Evaluation of the Highly Concentrated Human IgG Formulation Using Cyclodextrin Polypseudorotaxane Hydrogels.Preventing Aggregation of Recombinant Interferon beta-1b in Solution by Additives: Approach to an Albumin-Free Formulation.Changes of protein solutions during storage: a study of albumin pharmaceutical preparations.Dual Effect of Histidine on Polysorbate 20 Stability: Mechanistic Studies.High-throughput screening of excipients intended to prevent antigen aggregation at air-liquid interface.Physical Stability of Freeze-Dried Isomalt Diastereomer Mixtures.Modification of the kinetic stability of immunoglobulin G by solvent additives
P2860
Q33735618-99C69998-DFAA-4912-833D-EB3E42211D54Q34062756-2C1B4EE3-BBE9-400B-B2BE-B6EE56C6042BQ35033038-4E5B8A86-F3AB-4420-AFFA-EEE5CB0C259EQ35953047-87EDA55A-CA80-4CDD-BA51-F8262EC51141Q37724374-465DB217-4301-4BCD-B796-6C9EE1911DD1Q37873947-6CF14024-30E4-42C5-8692-BCE56BEB98FAQ38090687-7E9BF6A8-8E69-46A5-A3D7-498DFEE63BE2Q38111424-17A5E0AD-C333-41D8-90A0-2BDFB04229ADQ38264351-EDAD9BA9-4F4F-4F46-A7B5-0CE37FEBEEEBQ38324367-8FF7FAFD-8465-4FB9-B990-B3DAA1B461CDQ38616024-C4937050-A985-4010-9442-784DF60ED1BEQ38731409-43061457-F492-4AA3-93E2-702CFDDDBC4CQ39004225-640AC1F1-60E2-4953-8738-26EEC53A109AQ41987513-D1354B98-3118-49CA-B862-CFBE84B88E62Q43065707-9D93F258-F934-4760-9C19-8B97B3C59745Q43178482-A411D3C9-6C7E-47D6-93EE-F032FF6428F4Q48170015-B7AEE756-F71B-4EBF-885B-7FE4CC385C28Q50542693-39BB63D8-971A-4283-964B-BFC377D2CB80Q50857800-8A6A0EC3-0126-4027-BEA0-F057C8176A69Q57839816-055D22B9-A5F5-44BC-B636-8DD685BC4EF3
P2860
Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Recent trends in stabilising p ...... s in the choice of excipients.
@en
Recent trends in stabilising p ...... s in the choice of excipients.
@nl
type
label
Recent trends in stabilising p ...... s in the choice of excipients.
@en
Recent trends in stabilising p ...... s in the choice of excipients.
@nl
prefLabel
Recent trends in stabilising p ...... s in the choice of excipients.
@en
Recent trends in stabilising p ...... s in the choice of excipients.
@nl
P2860
P1476
Recent trends in stabilising p ...... ns in the choice of excipients
@en
P2093
Eva Horn Moeller
Susanne Hostrup
P2860
P304
P356
10.1517/17425240903199143
P407
P577
2009-11-01T00:00:00Z